Remedies proposed for NC Farma's Medley buy, review moves to Brazil CADE Tribunal
Brazil’s competition investigative unit has recommended approval of NC Farma’s acquisition of Sanofi’s Medley pharmaceutical portfolio after the companies proposed a merger-control agreement containing structural remedies to address concerns in two...To view the full article, register now.
Already a subscriber? Click here to view full article